DAMAGING CARDIAC GENE VARIANTS DETERMINE RESPONSE TO LVAD THERAPY
Journal of the American College of Cardiology(2015)
摘要
Left ventricular assist devices are routinely placed for end stage non-ischemic cardiomyopathy patients. Myocardial recovery on therapy is highly variable. Next Generation Sequencing gives us the ability to test for a wide range of damaging mutations. Our objective was to determine the association
更多查看译文
关键词
Left Ventricular Assist Device,Ventricular Assist Device,Cardiac Support Device,Left Ventricular Non-Compaction,Postinfarction Ventricular Septal Defect
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要